Ibrahim Mohey El-Deen

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Molecular Docking

Oxide Nanoparticles

Papillary Thyroid

Top Venues

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Ibrahim Mohey El-Deen, Elsayed H Eltamany, Nourhan M Ali
In vitro cytotoxicity screening of some 3-substituted-4-oxo-imidazolidin-2-(1H)-thione derivatives as anticancer drug. Future medicinal chemistry 16 (14) (2024)
Ibrahim Mohey El-Deen, Elsayed H Eltamany, Nourhan M Ali
In vitro cytotoxicity screening of some 3-substituted-4-oxo-imidazolidin-2-(1H)-thione derivatives as anticancer drug. Future medicinal chemistry 16 (14) (2024)
Dalal Nasser Binjawhar, Fawziah A Al-Salmi, Maha Ali Alghamdi, Ola A Abu Ali, Eman Fayad, Youstina William Rizzk, Nourhan M Ali, Ibrahim Mohey El-Deen, Elsayed H Eltamany
In vitro anti-breast cancer study of hybrid cinnamic acid derivatives bearing 2-thiohydantoin moiety. Future medicinal chemistry 16 (16) (2024)
Ibrahim Mohey El-Deen, Elsayed H Eltamany, Nourhan M Ali
In vitro cytotoxicity screening of some 3-substituted-4-oxo-imidazolidin-2-(1H)-thione derivatives as anticancer drug. Future medicinal chemistry 16 (14) (2024)
Ibrahim Mohey El-Deen, Elsayed H Eltamany, Nourhan M Ali
In vitro cytotoxicity screening of some 3-substituted-4-oxo-imidazolidin-2-(1H)-thione derivatives as anticancer drug. Future medicinal chemistry 16 (14) (2024)
Dalal Nasser Binjawhar, Fawziah A Al-Salmi, Maha Ali Alghamdi, Ola A Abu Ali, Eman Fayad, Youstina William Rizzk, Nourhan M Ali, Ibrahim Mohey El-Deen, Elsayed H Eltamany
In vitro anti-breast cancer study of hybrid cinnamic acid derivatives bearing 2-thiohydantoin moiety. Future medicinal chemistry (2024)